GlassScriptPhysician profile
Mariam Andar
NPI 1407163884
$11,024.38
in general payments reported to CMS, 2019-2025
28 companies · $2,653 in 2025
The $2,653 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,121 · 2022: $2,505 · 2023: $3,066 · 2024: $1,679 · 2025: $2,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,436 · Travel and Lodging: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,435.74 |
| Travel and Lodging | $962.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,031.07 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $1,428.05 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Amgen INC. | $937.50 | 2021-2025 | Repatha, Repatha |
| Abiomed | $751.26 | 2024-2025 | Impella |
| Cvrx, INC. | $533.77 | 2021-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $525.24 | 2021-2025 | Lifevest |
| Biosense Webster, INC. | $473.07 | 2021-2024 | Carto 3, Qdot Micro Catheter |
| Medtronic, INC. | $435.16 | 2021-2025 | Micra, Mycarelink, Aurora Ev-Icd Mri Surescan |
| Kestra Medical Technology Services, INC. | $425.86 | 2022-2025 | Assure Wcd |
| Boston Scientific Corporation | $263.58 | 2021-2025 | Watchman Flx, Avvigo Guidance System, Varithena Administration Pack |
| Astrazeneca Pharmaceuticals LP | $220.85 | 2021-2025 | Andexxa, Farxiga, Fasenra |
| E.R. Squibb & Sons, L.L.C. | $141.32 | 2021-2022 | |
| Penumbra, INC. | $140.06 | 2021 | |
| Chiesi USA, INC. | $116.80 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $91.14 | 2023-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $87.92 | 2023-2024 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $73.54 | 2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $69.06 | 2022-2023 | Arcalyst |
| Cardiovascular Systems INC. | $48.51 | 2021 | |
| Janssen Scientific Affairs, LLC | $34.46 | 2024 | Xarelto |
| Inari Medical, INC. | $34.23 | 2022 | |
| Janssen Pharmaceuticals, INC | $33.86 | 2021-2024 | Xarelto |
| Medline Industries LP | $26.74 | 2023 | |
| Biomerieux INC | $25.37 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $22.51 | 2024 | Arcalyst |
| Pfizer INC. | $20.71 | 2022 | |
| Scpharmaceuticals INC. | $19.88 | 2025 | |
| Biotronik INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Andar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.